Evaluation of Needles in Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreatic Cancer for Genetic Yield and Quality.

endoscopic ultrasound guided needle biopsy genetic yield needle size needle type pancreatic cancer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Sep 2024
Historique:
accepted: 01 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 3 10 2024
Statut: epublish

Résumé

Endoscopic ultrasound-guided fine needle biopsy (FNB) is the gold standard in tissue acquisition of pancreatic ductal adenocarcinoma (PDAC). There is a paucity of evidence of the impact of needle type or size on the genetic yield and quality. Patients 18 years and older with PDAC who underwent FNB were retrospectively identified from a single database from 2016 to 2021. Genetic quantity is measured in micrograms (µg) and quality defined by RNA or DNA integrity number (RIN and DIN). FNB needles examined were Acquire 22 gauge (Boston Scientific, Marlborough, MA, USA) and ProCore 22 and 20 gauges (Cook Medical, Bloomington, IN, USA). Two hundred seventy-seven patients were identified. ProCore 20G needle procured higher RNA quantity (4125.8µg, IQR: 2003.8, 5954.8, p = 0.012) compared to ProCore 22G (2050µg IQR: 966.4, 3181.6) and Acquire 22G (2310.6µg, IQR: 1439.3, 4312). Median DNA quantity was 3340.5µg (Acquire 22G), 2610.4µg (ProCore 22G) and 3499.7µg (ProCore 20G) (p = 0.763). Median DIN was 7.3 (Acquire 22G and ProCore 22G) and 7.4 (ProCore 20G) (p = 0.449). Median RIN was 3.0 (Acquire 22G and ProCore 22G) and 2.7 (ProCore 20G) (p = 0.886). ProCore 20G was associated with higher quantity of RNA. There were no differences in the quality acquired by different needles.

Sections du résumé

BACKGROUND BACKGROUND
Endoscopic ultrasound-guided fine needle biopsy (FNB) is the gold standard in tissue acquisition of pancreatic ductal adenocarcinoma (PDAC). There is a paucity of evidence of the impact of needle type or size on the genetic yield and quality.
METHODS METHODS
Patients 18 years and older with PDAC who underwent FNB were retrospectively identified from a single database from 2016 to 2021. Genetic quantity is measured in micrograms (µg) and quality defined by RNA or DNA integrity number (RIN and DIN). FNB needles examined were Acquire 22 gauge (Boston Scientific, Marlborough, MA, USA) and ProCore 22 and 20 gauges (Cook Medical, Bloomington, IN, USA).
RESULTS RESULTS
Two hundred seventy-seven patients were identified. ProCore 20G needle procured higher RNA quantity (4125.8µg, IQR: 2003.8, 5954.8, p = 0.012) compared to ProCore 22G (2050µg IQR: 966.4, 3181.6) and Acquire 22G (2310.6µg, IQR: 1439.3, 4312). Median DNA quantity was 3340.5µg (Acquire 22G), 2610.4µg (ProCore 22G) and 3499.7µg (ProCore 20G) (p = 0.763). Median DIN was 7.3 (Acquire 22G and ProCore 22G) and 7.4 (ProCore 20G) (p = 0.449). Median RIN was 3.0 (Acquire 22G and ProCore 22G) and 2.7 (ProCore 20G) (p = 0.886).
CONCLUSION CONCLUSIONS
ProCore 20G was associated with higher quantity of RNA. There were no differences in the quality acquired by different needles.

Identifiants

pubmed: 39360054
doi: 10.7759/cureus.68431
pmc: PMC11445693
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e68431

Informations de copyright

Copyright © 2024, Tiong et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Monash Health issued approval 80025. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Jonathan Tiong (J)

Department of Surgery, Monash Health, Melbourne, AUS.

Phi Nguyen (P)

Department of Surgery, Monash Health, Melbourne, AUS.

Mithra Sritharan (M)

Department of Surgery, Monash Health, Melbourne, AUS.

Joanne Lundy (J)

Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, AUS.

Henry Shen (H)

Department of Surgery, Monash Health, Melbourne, AUS.

Beena Kumar (B)

Department of Anatomical Pathology, Monash Health, Melbourne, AUS.

Michael Swan (M)

Department of Gastroenterology, Monash Health, Melbourne, AUS.

Brendan Jenkins (B)

Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, AUS.

Daniel Croagh (D)

Department of Surgery, Monash Health, Melbourne, AUS.

Classifications MeSH